A detailed history of Hoese & CO LLP transactions in Amgen Inc stock. As of the latest transaction made, Hoese & CO LLP holds 220 shares of AMGN stock, worth $70,228. This represents 0.06% of its overall portfolio holdings.

Number of Shares
220
Previous 220 -0.0%
Holding current value
$70,228
Previous $68,000 2.94%
% of portfolio
0.06%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 04, 2024

SELL
$255.7 - $288.46 $15,342 - $17,307
-60 Reduced 21.43%
220 $63,000
Q2 2022

Jul 12, 2022

SELL
$230.71 - $256.74 $16,149 - $17,971
-70 Reduced 20.0%
280 $68,000
Q3 2021

Oct 20, 2021

SELL
$212.27 - $248.7 $4,245 - $4,974
-20 Reduced 5.41%
350 $74,000
Q2 2021

Jul 13, 2021

BUY
$233.58 - $259.14 $4,671 - $5,182
20 Added 5.71%
370 $90,000
Q1 2021

May 03, 2021

BUY
$221.91 - $258.6 $77,668 - $90,510
350 New
350 $87,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hoese & CO LLP Portfolio

Follow Hoese & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoese & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Hoese & CO LLP with notifications on news.